Encyclopedia > Darbepoetin

  Article Content

Darbepoetin

Darbepoetin is a drug which increase red blood cell levels, and is used to treat anemia. It is in the same class of drugs as erythropoietin.

Its brand name is Aranesp, marketed by Amgen[?]. It was approved in September 2001 by the Food and Drug Administration for treatment of patients with chronic kidney failure.

Its use during the 2002 Winter Olympic Games to improve performance led to the disqualification of cross-country skiers Larissa Lazutina[?] and Olga Danilova[?] of Russia and Johann Mühlegg of Spain from their final races.



All Wikipedia text is available under the terms of the GNU Free Documentation License

 
  Search Encyclopedia

Search over one million articles, find something about almost anything!
 
 
  
  Featured Article
Kings Park, New York

... There are 5,574 housing units at an average density of 365.4/km² (946.1/mi²). The racial makeup of the town is 95.45% White, 0.84% African ...

 
 
 
This page was created in 33.6 ms